NFA
GILD icon

Nuveen Fund Advisors’s Gilead Sciences GILD Stock Holding History

Nuveen Fund Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-42,684
Closed -$3.22M – 191
2018
Q1 		$3.22M Sell
42,684
-24,229
-36% -$1.93M 1.48% 8
2017
Q4 		$4.79M Sell
66,913
-21,424
-24% -$1.63M 1.39% 16
2017
Q3 		$7.16M Sell
88,337
-14,326
-14% -$1.1M 1.46% 5
2017
Q2 		$7.27M Sell
102,663
-11,607
-10% -$772K 1.16% 9
2017
Q1 		$7.76M Buy
114,270
+30,324
+36% +$2.13M 1.03% 8
2016
Q4 		$6.01M Sell
83,946
-9,836
-10% -$731K 0.87% 16
2016
Q3 		$7.42M Buy
93,782
+2,588
+3% +$210K 1.03% 11
2016
Q2 		$7.61M Buy
+91,194
New +$8.09M 1.18% 5

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Fund Advisors's GILD Position: Q2 2018 in Review

Nuveen Fund Advisors sold out of Gilead Sciences (GILD) in Q2 2018, closing a stake of 42,684 shares — an estimated $3.22M sold.

Nuveen Fund Advisors first reported a position in GILD in Q2 2016 and held it in 8 quarters. The position peaked at $7.76M in Q1 2017. 1,522 funds tracked by Wall St. Rank hold GILD as of Q2 2018.

  • Nuveen Fund Advisors reported no remaining Gilead Sciences position as of Q2 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 42,684 Gilead Sciences shares in Q2 2018, an estimated $3.22M.
  • Nuveen Fund Advisors first reported a position in Gilead Sciences in Q2 2016 and held it in 8 quarters.
  • Nuveen Fund Advisors's Gilead Sciences position peaked at $7.76M in Q1 2017.
  • 1,522 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2018.

Based on Nuveen Fund Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.